European Commission approval received for Rezdiffra (resmetirom) for the treatment of MASH with moderate to advanced liver fibrosis – Madrigal Pharma
Madrigal Pharmaceuticals Inc. announced that the European Commission (EC) has granted conditional marketing authorization for Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic MASH with moderate to… read more.
